Biogen Inc.’s new at-home Alzheimer’s drug will give the company an edge over rival Eli Lilly Co.’s competing therapy, its chief executive officer said in an interview. Lilly’s drug, Kisunla, launched ...

U.S. pharmaceutical company Eli Lilly is expected to unveil the top-line results (key findings from phase 3 clinical trials) of its new drug component ‘Lemternectuk’, being developed as a successor to ...

Eli Lilly's potential Alzheimer's disease treatment failed to slow mental decline in two late-stage studies, but combined data from both trials showed promising results in patients with ...

By Rishika Sadam and Kashish Tandon HYDERABAD, Feb 17 (Reuters) - Mounjaro-maker Eli Lilly wants to turn India into a hub for its global supply chain, a senior executive at the U.S. drugmaker said, as ...